EDOXABAN TOSILATE: 374 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
374
Total FAERS Reports
55 (14.7%)
Deaths Reported
256
Hospitalizations
374
As Primary/Secondary Suspect
41
Life-Threatening
20
Disabilities
Active Ingredient: EDOXABAN TOSILATE MONOHYDRATE ·
First Report: 2009 · Latest Report: 20170317
What Are the Most Common EDOXABAN TOSILATE Side Effects?
#1 Most Reported
Cerebral infarction
44 reports (11.8%)
#2 Most Reported
Anaemia
15 reports (4.0%)
#3 Most Reported
Off label use
14 reports (3.7%)
All EDOXABAN TOSILATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Cerebral infarction | 44 | 11.8% | 9 | 37 |
| Anaemia | 15 | 4.0% | 0 | 12 |
| Embolic stroke | 14 | 3.7% | 0 | 12 |
| Off label use | 14 | 3.7% | 3 | 6 |
| Cerebrovascular accident | 12 | 3.2% | 0 | 11 |
| Epistaxis | 11 | 2.9% | 4 | 5 |
| Pulmonary embolism | 11 | 2.9% | 3 | 7 |
| Gastrointestinal haemorrhage | 10 | 2.7% | 5 | 7 |
| Cerebral haemorrhage | 9 | 2.4% | 5 | 6 |
| Death | 9 | 2.4% | 9 | 2 |
| Haemorrhage | 9 | 2.4% | 0 | 4 |
| Haemoglobin decreased | 8 | 2.1% | 0 | 7 |
| Interstitial lung disease | 8 | 2.1% | 3 | 7 |
| Platelet count decreased | 8 | 2.1% | 1 | 5 |
| Fall | 7 | 1.9% | 2 | 4 |
| Melaena | 7 | 1.9% | 1 | 3 |
| Renal impairment | 7 | 1.9% | 2 | 6 |
| Drug interaction | 6 | 1.6% | 0 | 4 |
| Pneumonia aspiration | 6 | 1.6% | 5 | 3 |
| Pyrexia | 6 | 1.6% | 0 | 6 |
Who Reports EDOXABAN TOSILATE Side Effects? Age & Gender Data
Gender: 49.3% female, 50.7% male. Average age: 74.9 years. Most reports from: JP. View detailed demographics →
Is EDOXABAN TOSILATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2009 | 1 | 1 | 0 |
| 2012 | 1 | 0 | 0 |
| 2014 | 2 | 0 | 0 |
| 2015 | 91 | 14 | 64 |
| 2016 | 164 | 24 | 122 |
| 2017 | 26 | 5 | 19 |
What Is EDOXABAN TOSILATE Used For?
| Indication | Reports |
|---|---|
| Atrial fibrillation | 191 |
| Product used for unknown indication | 64 |
| Deep vein thrombosis | 44 |
| Embolism venous | 21 |
| Pulmonary embolism | 20 |
| Cerebral infarction | 8 |
| Joint arthroplasty | 5 |
| Thrombosis prophylaxis | 5 |
EDOXABAN TOSILATE vs Alternatives: Which Is Safer?
EDOXABAN TOSILATE vs EFALIZUMAB
EDOXABAN TOSILATE vs EFANESOCTOCOG ALFA
EDOXABAN TOSILATE vs EFAVIRENZ
EDOXABAN TOSILATE vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL
EDOXABAN TOSILATE vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL
EDOXABAN TOSILATE vs EFFEXOR
EDOXABAN TOSILATE vs EFFIENT
EDOXABAN TOSILATE vs EFGARTIGIMOD ALFA
EDOXABAN TOSILATE vs EFGARTIGIMOD ALFA-FCAB
EDOXABAN TOSILATE vs EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC
Official FDA Label for EDOXABAN TOSILATE
Official prescribing information from the FDA-approved drug label.